Effect of rapid influenza testing on the clinical management of paediatric influenza.
Identifieur interne : 000419 ( Main/Exploration ); précédent : 000418; suivant : 000420Effect of rapid influenza testing on the clinical management of paediatric influenza.
Auteurs : Lance C. Jennings [Nouvelle-Zélande] ; Heino Skopnik ; Isabel Burckhardt ; Irene Hribar ; Luc Del Piero ; Klaus A. DeichmannSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2009.
Descripteurs français
- KwdFr :
- Allemagne (MeSH), Antiviraux (usage thérapeutique), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Grippe humaine (diagnostic), Grippe humaine (traitement médicamenteux), Humains (MeSH), Mâle (MeSH), Nourrisson (MeSH), Prise en charge personnalisée du patient (MeSH), Recherche sur les services de santé (MeSH), Techniques de diagnostic moléculaire (statistiques et données numériques), Techniques de laboratoire clinique (méthodes).
- MESH :
- diagnostic : Grippe humaine.
- méthodes : Techniques de laboratoire clinique.
- statistiques et données numériques : Techniques de diagnostic moléculaire.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux.
- Allemagne, Enfant, Enfant d'âge préscolaire, Enquêtes et questionnaires, Femelle, Humains, Mâle, Nourrisson, Prise en charge personnalisée du patient, Recherche sur les services de santé.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Case Management (MeSH), Child (MeSH), Child, Preschool (MeSH), Clinical Laboratory Techniques (methods), Female (MeSH), Germany (MeSH), Health Services Research (MeSH), Humans (MeSH), Infant (MeSH), Influenza, Human (diagnosis), Influenza, Human (drug therapy), Male (MeSH), Molecular Diagnostic Techniques (statistics & numerical data), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- diagnosis : Influenza, Human.
- drug therapy : Influenza, Human.
- methods : Clinical Laboratory Techniques.
- statistics & numerical data : Molecular Diagnostic Techniques.
- Case Management, Child, Child, Preschool, Female, Germany, Health Services Research, Humans, Infant, Male, Surveys and Questionnaires.
Abstract
BACKGROUND
Rapid tests are now widely available to assist the diagnosis of influenza; implementation may optimise the use of antiviral and antibiotic agents in the clinical management of influenza.
OBJECTIVE
To explore the clinical management of children with influenza-like illness (ILI) when rapid influenza tests were and were not performed.
METHODS
Between 15 January 2007 and 30 April 2007, a standardised questionnaire was used to record the clinical features of children aged 1-12 years who presented to office-based paediatricians in Germany with febrile ILI during periods of local influenza activity. For each paediatric contact, a clinical diagnosis of either 'influenza positive', 'influenza negative' or 'suspected ILI' was made. Where performed, the outcome of a Clearview Exact Influenza A + B rapid test was recorded. Prescriptions for antiviral agents and antibiotic medications were also recorded.
RESULTS
A total of 16 907 questionnaires were evaluated. After fever (an entry criteria for all children), cough (84.6%), fatigue/decreased activity (83.0%), rhinorrhoea (73.7%) and headache (67.1%) were the most common symptoms. Influenza was clinically diagnosed in 56.8% (9596/16 907) of cases. The antiviral oseltamivir was prescribed for 24.6% (178/725) of children who were influenza positive by symptom assessment alone and 60.1% (4618/7685) of children who were influenza positive by rapid test. Antibiotics were less commonly prescribed for children who were influenza positive by rapid test [3.5% (271/7685) versus 17.2% (125/725) for symptom assessment alone].
CONCLUSIONS
In children with ILI, a positive rapid test result for influenza promotes the rational use of antiviral agents and reduces the inappropriate use of antibiotic medications.
DOI: 10.1111/j.1750-2659.2009.00079.x
PubMed: 19453485
PubMed Central: PMC4634694
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of rapid influenza testing on the clinical management of paediatric influenza.</title><author><name sortKey="Jennings, Lance C" sort="Jennings, Lance C" uniqKey="Jennings L" first="Lance C" last="Jennings">Lance C. Jennings</name><affiliation wicri:level="1"><nlm:affiliation>Canterbury Health Laboratories, Christchurch, New Zealand. lance.jennings@cdhb.govt.nz</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Canterbury Health Laboratories, Christchurch</wicri:regionArea><wicri:noRegion>Christchurch</wicri:noRegion></affiliation></author><author><name sortKey="Skopnik, Heino" sort="Skopnik, Heino" uniqKey="Skopnik H" first="Heino" last="Skopnik">Heino Skopnik</name></author><author><name sortKey="Burckhardt, Isabel" sort="Burckhardt, Isabel" uniqKey="Burckhardt I" first="Isabel" last="Burckhardt">Isabel Burckhardt</name></author><author><name sortKey="Hribar, Irene" sort="Hribar, Irene" uniqKey="Hribar I" first="Irene" last="Hribar">Irene Hribar</name></author><author><name sortKey="Del Piero, Luc" sort="Del Piero, Luc" uniqKey="Del Piero L" first="Luc" last="Del Piero">Luc Del Piero</name></author><author><name sortKey="Deichmann, Klaus A" sort="Deichmann, Klaus A" uniqKey="Deichmann K" first="Klaus A" last="Deichmann">Klaus A. Deichmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19453485</idno><idno type="pmid">19453485</idno><idno type="doi">10.1111/j.1750-2659.2009.00079.x</idno><idno type="pmc">PMC4634694</idno><idno type="wicri:Area/Main/Corpus">000412</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000412</idno><idno type="wicri:Area/Main/Curation">000412</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000412</idno><idno type="wicri:Area/Main/Exploration">000412</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effect of rapid influenza testing on the clinical management of paediatric influenza.</title><author><name sortKey="Jennings, Lance C" sort="Jennings, Lance C" uniqKey="Jennings L" first="Lance C" last="Jennings">Lance C. Jennings</name><affiliation wicri:level="1"><nlm:affiliation>Canterbury Health Laboratories, Christchurch, New Zealand. lance.jennings@cdhb.govt.nz</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Canterbury Health Laboratories, Christchurch</wicri:regionArea><wicri:noRegion>Christchurch</wicri:noRegion></affiliation></author><author><name sortKey="Skopnik, Heino" sort="Skopnik, Heino" uniqKey="Skopnik H" first="Heino" last="Skopnik">Heino Skopnik</name></author><author><name sortKey="Burckhardt, Isabel" sort="Burckhardt, Isabel" uniqKey="Burckhardt I" first="Isabel" last="Burckhardt">Isabel Burckhardt</name></author><author><name sortKey="Hribar, Irene" sort="Hribar, Irene" uniqKey="Hribar I" first="Irene" last="Hribar">Irene Hribar</name></author><author><name sortKey="Del Piero, Luc" sort="Del Piero, Luc" uniqKey="Del Piero L" first="Luc" last="Del Piero">Luc Del Piero</name></author><author><name sortKey="Deichmann, Klaus A" sort="Deichmann, Klaus A" uniqKey="Deichmann K" first="Klaus A" last="Deichmann">Klaus A. Deichmann</name></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Case Management (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Clinical Laboratory Techniques (methods)</term><term>Female (MeSH)</term><term>Germany (MeSH)</term><term>Health Services Research (MeSH)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Influenza, Human (diagnosis)</term><term>Influenza, Human (drug therapy)</term><term>Male (MeSH)</term><term>Molecular Diagnostic Techniques (statistics & numerical data)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne (MeSH)</term><term>Antiviraux (usage thérapeutique)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (diagnostic)</term><term>Grippe humaine (traitement médicamenteux)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Nourrisson (MeSH)</term><term>Prise en charge personnalisée du patient (MeSH)</term><term>Recherche sur les services de santé (MeSH)</term><term>Techniques de diagnostic moléculaire (statistiques et données numériques)</term><term>Techniques de laboratoire clinique (méthodes)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Laboratory Techniques</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Techniques de laboratoire clinique</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Molecular Diagnostic Techniques</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Techniques de diagnostic moléculaire</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case Management</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Germany</term><term>Health Services Research</term><term>Humans</term><term>Infant</term><term>Male</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Allemagne</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Prise en charge personnalisée du patient</term><term>Recherche sur les services de santé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Rapid tests are now widely available to assist the diagnosis of influenza; implementation may optimise the use of antiviral and antibiotic agents in the clinical management of influenza.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To explore the clinical management of children with influenza-like illness (ILI) when rapid influenza tests were and were not performed.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Between 15 January 2007 and 30 April 2007, a standardised questionnaire was used to record the clinical features of children aged 1-12 years who presented to office-based paediatricians in Germany with febrile ILI during periods of local influenza activity. For each paediatric contact, a clinical diagnosis of either 'influenza positive', 'influenza negative' or 'suspected ILI' was made. Where performed, the outcome of a Clearview Exact Influenza A + B rapid test was recorded. Prescriptions for antiviral agents and antibiotic medications were also recorded.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A total of 16 907 questionnaires were evaluated. After fever (an entry criteria for all children), cough (84.6%), fatigue/decreased activity (83.0%), rhinorrhoea (73.7%) and headache (67.1%) were the most common symptoms. Influenza was clinically diagnosed in 56.8% (9596/16 907) of cases. The antiviral oseltamivir was prescribed for 24.6% (178/725) of children who were influenza positive by symptom assessment alone and 60.1% (4618/7685) of children who were influenza positive by rapid test. Antibiotics were less commonly prescribed for children who were influenza positive by rapid test [3.5% (271/7685) versus 17.2% (125/725) for symptom assessment alone].</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>In children with ILI, a positive rapid test result for influenza promotes the rational use of antiviral agents and reduces the inappropriate use of antibiotic medications.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19453485</PMID><DateCompleted><Year>2009</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Effect of rapid influenza testing on the clinical management of paediatric influenza.</ArticleTitle><Pagination><MedlinePgn>91-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1750-2659.2009.00079.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rapid tests are now widely available to assist the diagnosis of influenza; implementation may optimise the use of antiviral and antibiotic agents in the clinical management of influenza.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the clinical management of children with influenza-like illness (ILI) when rapid influenza tests were and were not performed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between 15 January 2007 and 30 April 2007, a standardised questionnaire was used to record the clinical features of children aged 1-12 years who presented to office-based paediatricians in Germany with febrile ILI during periods of local influenza activity. For each paediatric contact, a clinical diagnosis of either 'influenza positive', 'influenza negative' or 'suspected ILI' was made. Where performed, the outcome of a Clearview Exact Influenza A + B rapid test was recorded. Prescriptions for antiviral agents and antibiotic medications were also recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 16 907 questionnaires were evaluated. After fever (an entry criteria for all children), cough (84.6%), fatigue/decreased activity (83.0%), rhinorrhoea (73.7%) and headache (67.1%) were the most common symptoms. Influenza was clinically diagnosed in 56.8% (9596/16 907) of cases. The antiviral oseltamivir was prescribed for 24.6% (178/725) of children who were influenza positive by symptom assessment alone and 60.1% (4618/7685) of children who were influenza positive by rapid test. Antibiotics were less commonly prescribed for children who were influenza positive by rapid test [3.5% (271/7685) versus 17.2% (125/725) for symptom assessment alone].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In children with ILI, a positive rapid test result for influenza promotes the rational use of antiviral agents and reduces the inappropriate use of antibiotic medications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jennings</LastName><ForeName>Lance C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Canterbury Health Laboratories, Christchurch, New Zealand. lance.jennings@cdhb.govt.nz</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skopnik</LastName><ForeName>Heino</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Burckhardt</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Hribar</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Del Piero</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Deichmann</LastName><ForeName>Klaus A</ForeName><Initials>KA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019090" MajorTopicYN="Y">Case Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="Y">Health Services Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025202" MajorTopicYN="N">Molecular Diagnostic Techniques</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19453485</ArticleId><ArticleId IdType="pii">IRV079</ArticleId><ArticleId IdType="doi">10.1111/j.1750-2659.2009.00079.x</ArticleId><ArticleId IdType="pmc">PMC4634694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 1998 Dec 12;352(9144):1877-81</Citation><ArticleIdList><ArticleId IdType="pubmed">9863784</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2000 Oct;182(4):1218-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10979921</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):232-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10648764</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Sep 25;337(13):874-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9302301</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17625497</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pediatr Adolesc Med. 2006 Jul;160(7):713-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16818837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1970 Jul-Aug;122(1):16-25</Citation><ArticleIdList><ArticleId IdType="pubmed">5433709</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Jan 15;25(5):780-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17101199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2006 Feb;25(2):160-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16462295</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2006 Sep;118(3):1167-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16951012</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Oct 15;41(8):1198-200</Citation><ArticleIdList><ArticleId IdType="pubmed">16163640</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pediatr Adolesc Med. 2002 Jan;156(1):41-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11772189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2003 Jul 28;163(14):1667-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12885681</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2005 Jul;90(7):741-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15855178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2001 Feb;20(2):127-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11224828</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16874296</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation><ArticleIdList><ArticleId IdType="pubmed">10648763</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2006 Jul;95(7):778-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16801171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 May 27;355(9218):1845-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10866439</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2007 Jul 2;187(1):36-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17605701</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2000 May;19(5):410-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10819336</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):963-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17882126</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Aug 14;24(33-34):5970-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16759761</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1978 Mar 16;298(11):587-92</Citation><ArticleIdList><ArticleId IdType="pubmed">628375</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2003 Jan;51(1):123-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12493796</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Oct 15;190(8):1369-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15378427</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2000 Mar;181(3):831-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10720501</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2000 Apr;19(4):303-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10783019</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Feb 1;36(3):299-305</Citation><ArticleIdList><ArticleId IdType="pubmed">12539071</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2008 Apr;14(4):298-306</Citation><ArticleIdList><ArticleId IdType="pubmed">18093237</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2003 Jun;88(6):525-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12765923</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 1993 Feb;110(1):145-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8432318</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Res Opin. 2007 Mar;23(3):523-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17355734</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2004 Aug 13;53(31):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15306754</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Jul 6;355(1):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16822994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2003 Aug;112(2):363-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12897288</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Nouvelle-Zélande</li></country></list><tree><noCountry><name sortKey="Burckhardt, Isabel" sort="Burckhardt, Isabel" uniqKey="Burckhardt I" first="Isabel" last="Burckhardt">Isabel Burckhardt</name><name sortKey="Deichmann, Klaus A" sort="Deichmann, Klaus A" uniqKey="Deichmann K" first="Klaus A" last="Deichmann">Klaus A. Deichmann</name><name sortKey="Del Piero, Luc" sort="Del Piero, Luc" uniqKey="Del Piero L" first="Luc" last="Del Piero">Luc Del Piero</name><name sortKey="Hribar, Irene" sort="Hribar, Irene" uniqKey="Hribar I" first="Irene" last="Hribar">Irene Hribar</name><name sortKey="Skopnik, Heino" sort="Skopnik, Heino" uniqKey="Skopnik H" first="Heino" last="Skopnik">Heino Skopnik</name></noCountry><country name="Nouvelle-Zélande"><noRegion><name sortKey="Jennings, Lance C" sort="Jennings, Lance C" uniqKey="Jennings L" first="Lance C" last="Jennings">Lance C. Jennings</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000419 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000419 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19453485
|texte= Effect of rapid influenza testing on the clinical management of paediatric influenza.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19453485" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |